Keywords: سیبوترامین; Sibutramine; Endothelial cell; Apoptosis; Reactive oxygen species; Nitric oxide;
مقالات ISI سیبوترامین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سیبوترامین; Sibutramine; Fibrosis; Mast cells; iBALT; Collagen
Keywords: سیبوترامین; Mid-infrared; Near-infrared; Sibutramine; Raman; Phenolphthalein; AnorecticsMCC, microcrystalline cellulose; ATR, attenuated total reflectance; LVF, linear variable filter; SNV, standard normal variate; PC, principal component; PCA, principal component an
Keywords: سیبوترامین; ATR-IR; Sibutramine; Adulterated dietary supplements; Chemometrics; Mobile detection approaches;
Keywords: سیبوترامین; Antiobesity drugs; Congenital malformations; Orlistat; Ribonabant; Sibutramine
Keywords: سیبوترامین; Sibutramine; Acute treatment; Vas deferens; Young rats; Sympathetic neurotransmission;
Keywords: سیبوترامین; Weight loss drugs; Dietary supplement; Sibutramine; Flow injection; LC-MS/MS;
Keywords: سیبوترامین; Sibutramine; Monoamine; Transporter; Occupancy; Depression; Thermogenesis
Keywords: سیبوترامین; Dietary supplement; Sibutramine; Ion mobility spectrometry; Mass spectrometry; Nuclear magnetic resonance;
Keywords: سیبوترامین; Insulin resistance; Free fatty acids; Obesity; Ciliary neurotrophic factor; Sibutramine
A rapid ATR-FTIR spectroscopic method for detection of sibutramine adulteration in tea and coffee based on hierarchical cluster and principal component analyses
Keywords: سیبوترامین; Sibutramine; ATR-FTIR; Chemometrics; Adulteration; Slimming tea;
Effects of CYP3A5, CYP2C19, and CYP2B6 on the clinical efficacy and adverse outcomes of sibutramine therapy: A crucial role for the CYP2B6*6 allele
Keywords: سیبوترامین; CYP2B6; Polymorphisms; Sibutramine
Systemic treatment with d-fenfluramine, but not sibutramine, blocks cue-induced reinstatement of food-seeking behavior in the rat
Keywords: سیبوترامین; Fenfluramine; Sibutramine; Reinstatement; Motivation; Food-seeking;
Trends in counterfeits amphetamine-type stimulants after its prohibition in Brazil
Keywords: سیبوترامین; Amphetamine-type stimulants; Fenproporex; Sibutramine; Forensic analysis
MRI allows for longitudinal quantitative analysis of body fat composition in rats: An analysis of sibutramine-associated changes at the group level
Keywords: سیبوترامین; Magnetic resonance imaging; Subcutaneous fat volume; Visceral fat volume; Body fat composition; Rats; Sibutramine
Sibutramine administration decreases serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome
Keywords: سیبوترامین; Sibutramine; Anti-Müllerian hormone; Polycystic ovary syndrome; Weight reduction; Insulin resistance
Quantitative determination of sibutramine in adulterated herbal slimming formulations by TLC-image analysis method
Keywords: سیبوترامین; Sibutramine; Herbal slimming formulations; TLC-image analysis; TLC-densitometry
Comparative determination of sibutramine as an adulterant in natural slimming products by HPLC and HPTLC densitometry
Keywords: سیبوترامین; High-performance thin layer chromatography (HPTLC); Method validation; Quantitative analysis; Sibutramine; Slimming products
Characterization, stability, and pharmacokinetics of sibutramine/β-cyclodextrin inclusion complex
Keywords: سیبوترامین; Cyclodextrin; Inclusion complex; Sibutramine; Stability; Dissolution; Pharmacokinetics
Molecular and cellular pharmacologyChanges of cytosolic calcium and contractility of young rat vas deferens by acute treatment with amphetamine, fluoxetine or sibutramine
Keywords: سیبوترامین; Amphetamine; Sibutramine; Fluoxetine; Pretreatment; Young rat vas deferens; Calcium;
Quantification of sibutramine and its two metabolites in human plasma by LC–ESI-MS/MS and its application in a bioequivalence study
Keywords: سیبوترامین; LC–ESI-MS/MS; Sibutramine; Human plasma; Bioequivalence; Pharmacokinetic study
Determination of sibutramine with a new sensor based on luminol electrochemiluminescence
Keywords: سیبوترامین; Flow injection; Electrochemiluminescence; Determination; Sibutramine; Luminol;
Reverse migration order of sibutramine enantiomers as a function of cyclodextrin concentration in capillary electrophoresis
Keywords: سیبوترامین; Sibutramine; Capillary electrophoresis; Enantiomer migration order; β-Cyclodextrin; Binding constant
X-ray powder diffractometry and liquid chromatography studies of sibutramine and its analogues content in herbal dietary supplements
Keywords: سیبوترامین; X-Ray powder diffractometry; Coulometric electrode array detection; Sibutramine; N-monodesmethylsibutramine; N,N-didesmethylsibutramine
Management of obesity and overweight
Keywords: سیبوترامین; bariatric surgery; counterweight; liraglutide; orlistat; sibutramine
Enantioselective determination of sibutramine and its active metabolites in human plasma
Keywords: سیبوترامین; Sibutramine; Active metabolite; Chiral separation; Human plasma; LC–MS/MS; Pharmacokinetics
Contrasting effects of systemic and central sibutramine administration on the intake of a palatable diet in the rat
Keywords: سیبوترامین; Feeding; Food intake; Nucleus accumbens; Paraventricular nucleus of the hypothalamus; Sibutramine;
Management of obesity in menopause: Diet, exercise, pharmacotherapy and bariatric surgery
Keywords: سیبوترامین; Menopause; Obesity; HPA axis; Sibutramine; Orlistat
Sibutramine & naloxone: Infra-additive interaction in the regulation of appetite?
Keywords: سیبوترامین; Appetite; Food intake; Behavioural satiety sequence; Weight gain; Naloxone; Sibutramine; Monotherapy; Polytherapy; Rats
Effects of acute low-dose combined treatment with rimonabant and sibutramine on appetite and weight gain in rats
Keywords: سیبوترامین; Food intake; Feeding behaviour; Behavioural satiety sequence; Rimonabant; Sibutramine; Low doses; Polytherapy; Monotherapy; Rats;
Analysis of enantiomers of sibutramine and its metabolites in rat plasma by liquid chromatography-mass spectrometry using a chiral stationary-phase column
Keywords: سیبوترامین; Sibutramine; Mono-desmethylsibutramine; Di-desmethylsibutramine; Chiral separation; LC/MS/MS;
Serum adiponectin and resistin in rats under three isocaloric diets: The effect of sibutramine
Keywords: سیبوترامین; Adiponectin; Resistin; Sibutramine; Fat to lean ratio; Isocaloric diets
Sibutramine-induced anorexia: Potent, dose-dependent and behaviourally-selective profile in male rats
Keywords: سیبوترامین; Appetite; Food intake; Weight gain; Behavioural satiety sequence; Serotonin; Sibutramine; Rats
Multiple effects of sibutramine on ejaculation and on vas deferens and seminal vesicle contractility
Keywords: سیبوترامین; Abnormal ejaculation; Premature ejaculation; Seminal vesicle; Sibutramine; Vas deferens
Analysis of sibutramine metabolites as N-trifluoroacetamide and O-trimethylsilyl derivatives by gas chromatography–mass spectrometry in urine
Keywords: سیبوترامین; Doping; Sibutramine; GC-MS; WADA; MSTFA/MBTFA
Pharmacotherapy for the Obese Patient
Keywords: سیبوترامین; Obesity; Pharmacotherapy; Orlistat; Phentermine; Sibutramine;
The Relationship of Obesity and Obstructive Sleep Apnea
Keywords: سیبوترامین; Sleep-disordered breathing; Obesity; Medical weight-loss therapy; Bariatric surgery; Dietary weight loss; Sibutramine;
Effects of sibutramine and orlistat on mood in obese and overweight subjects: A randomised study
Keywords: سیبوترامین; Weight loss; Sibutramine; Orlistat; Mood; Depression
Orlistat and sibutramine beyond weight loss
Keywords: سیبوترامین; Orlistat; Sibutramine; Weight loss; Total cholesterol; Lipid profile; Cardiovascular risk
Novel effects of macrostemonoside A, a compound from Allium macrostemon Bung, on hyperglycemia, hyperlipidemia, and visceral obesity in high-fat diet-fed C57BL/6 mice
Keywords: سیبوترامین; Macrostemonoside A; Sibutramine; Metabolic syndrome; Type 2 diabetes; Obesity; Visfatin; Peroxisome proliferators-activated receptor gamma 2
Effect of sibutramine on weight reduction in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
Keywords: سیبوترامین; Polycystic ovary syndrome; sibutramine; randomized clinical trial; obesity
Crystal chemistry of sibutramine: Thermal, diffractometric and spectroscopic characterization
Keywords: سیبوترامین; sibutramine; crystal and molecular structure; powder diffraction; solid state NMR;
Cardiovascular disease in obesity: A review of related risk factors and risk-reduction strategies
Keywords: سیبوترامین; Adiponectin; Bariatric surgery; Cardiovascular disease; Leptin; Metabolic syndrome; Obesity; Orlistat; Rimonabant; Risk factors; Sibutramine
Therapeutic Options for Modifying Cardiometabolic Risk Factors
Keywords: سیبوترامین; Metabolic syndrome; Metformin; Obesity; Orlistat; Rimonabant; Sibutramine;
Pharmacotherapy for obesity
Keywords: سیبوترامین; Obesity; Drugs; Weight loss; Appetite; Clinical trials; Orlistat/Xenical; Sibutramine; Rimonabant/Accompha
Management of obesity and overweight
Keywords: سیبوترامین; counterweight; orlistat; sibutramine; rimonabant; bariatric surgery
Cardiovascular responses to melanocortin 4-receptor stimulation in conscious unrestrained normotensive rats
Keywords: سیبوترامین; Melanocortins; Sibutramine; Food intake; Blood pressure; Heart rate; Body temperature; Locomotor activity; Sympathetic nerve activity
Effects of sibutramine on the appetitive and consummatory aspects of feeding in non-human primates
Keywords: سیبوترامین; Food intake; Baboon; Motivation; Sibutramine; Dexfenfluramine
Neurochemical, neuroautonomic and neuropharmacological acute effects of sibutramine in healthy subjects
Keywords: سیبوترامین; Sibutramine; Plasma noradrenaline; Plasma adrenaline; Plasma dopamine; Blood serotonin; Diastolic blood pressure; Neural sympathetic activity
Sibutramine does not worsen sleep apnea syndrome: a randomized double-blind placebo-controlled study
Keywords: سیبوترامین; Sleep; Sleep apnea syndrome; Obstructive sleep apnea; Sibutramine; Obesity; Drug adverse effects; Anti-obesity agents; Drug safety;